BiotechTube
Home/Aroa Biosurgery/James Agnew
JA

James Agnew

Chief Financial Officer and Joint Company Secretary

Aroa Biosurgery

Therapeutic Areas

Soft Tissue RepairWound ManagementSurgical Reconstruction

Aroa Biosurgery Pipeline

DrugIndicationPhase
Endoform™ Dermal TemplateChronic non‑healing woundsCommercial
Myriad Matrix™Complex surgical wounds and reconstructionCommercial
Myriad Morcells™Cellular ECM therapy for soft‑tissue repairCommercial
Symphony™Combination cellular‑tissue product (CTP) with hyaluronic acidCommercial
Reinforced BioscaffoldsVentral hernia repair and abdominal wall reconstructionCommercial

Leadership Team at Aroa Biosurgery

BW
Brian Ward
Chief Executive Officer
BC
Barnaby C. H. May
Chief Scientific Officer
YW
Yasmin Winchester
Chief of Technical Operations
RS
Rod Stanley
Chief Operating Officer
View full Aroa Biosurgery profile